Found: 76
Select item for more details and to access through your institution.
Mutations in the protease gene associated with virological failure to lopinavir/ritonavir-containing regimens.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 6, p. 1462
- By:
- Publication type:
- Article
Efficacy and safety of nucleoside reverse transcriptase inhibitor-sparing salvage therapy for multidrug-resistant HIV-1 infection based on new-class and new-generation antiretrovirals.
- Published in:
- 2011
- By:
- Publication type:
- Correction Notice
Efficacy and safety of nucleoside reverse transcriptase inhibitor-sparing salvage therapy for multidrug-resistant HIV-1 infection based on new-class and new-generation antiretrovirals.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2011, v. 66, n. 2, p. 358, doi. 10.1093/jac/dkq432
- By:
- Publication type:
- Article
Long-distance interactive expert advice in highly treatment-experienced HIV-infected patients.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2008, v. 61, n. 1, p. 206
- By:
- Publication type:
- Article
Evolving AIDS- and non-AIDS Mortality and Predictors in the PISCIS Cohort of People Living With HIV in Catalonia and the Balearic Islands (Spain), 1998–2020.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 4, p. 1, doi. 10.1093/ofid/ofae132
- By:
- Publication type:
- Article
Laboratory Report of HIV-1 Low-Level Viremia.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 2, p. 1, doi. 10.1093/ofid/ofad667
- By:
- Publication type:
- Article
Disparities in Coronavirus Disease 2019 Clinical Outcomes and Vaccination Coverage Among Migrants With Human Immunodeficiency Virus in the PISCIS Cohort: A Population-Based Propensity Score–Matched Analysis.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 1, p. 1, doi. 10.1093/ofid/ofad693
- By:
- Publication type:
- Article
Very-Low-Level Viremia, Inflammatory Biomarkers, and Associated Baseline Variables: Three-Year Results of the Randomized TANGO Study.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 1, p. 1, doi. 10.1093/ofid/ofad626
- By:
- Publication type:
- Article
Virologic Response to Dolutegravir Plus Lamivudine in People With Suppressed Human Immunodeficiency Virus Type 1 and Historical M184V/I: A Systematic Literature Review and Meta-analysis.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 11, p. 1, doi. 10.1093/ofid/ofad526
- By:
- Publication type:
- Article
Changes in Inflammatory and Atherogenesis Biomarkers With the 2-Drug Regimen Dolutegravir Plus Lamivudine in Antiretroviral Therapy–Experienced, Virologically Suppressed People With HIV-1: A Systematic Literature Review.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 4, p. 1, doi. 10.1093/ofid/ofac068
- By:
- Publication type:
- Article
Effectiveness and tolerability of abacavir-lamivudine-nevirapine (ABC/3TC/NVP) in a multicentre cohort of HIV-infected, ARV-naïve patients.
- Published in:
- Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19773
- By:
- Publication type:
- Article
Hidden costs of HIV treatment in Spain: inefficiency of the antiretroviral drug packaging.
- Published in:
- Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19609
- By:
- Publication type:
- Article
Long term effectiveness of once-daily unboosted atazanavir plus abacavir/lamivudine as a switch strategy in subjects with virological suppression.
- Published in:
- Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19810
- By:
- Publication type:
- Article
Prescription of antimicrobials in primary health care as a marker to identify people living with undiagnosed HIV infection, Denmark, 1998 to 2016.
- Published in:
- Eurosurveillance (15607917), 2019, v. 24, n. 41, p. 9, doi. 10.2807/1560-7917.ES.2019.24.41.1900225
- By:
- Publication type:
- Article
Natural History of Anal Squamous Intraepithelial Lesions in HIV-Positive Men with Normal Baseline Cytology.
- Published in:
- AIDS Patient Care & STDs, 2019, v. 33, n. 11, p. 459, doi. 10.1089/apc.2019.0186
- By:
- Publication type:
- Article
Lymphogranuloma Venerium Proctitis in the Setting of HIV: A Case Report and Differential Diagnosis.
- Published in:
- AIDS Patient Care & STDs, 2009, v. 23, n. 7, p. 493, doi. 10.1089/apc.2008.0261
- By:
- Publication type:
- Article
Clinical outcomes after IL-6 blockade in patients with COVID-19 and HIV: a case series.
- Published in:
- AIDS Research & Therapy, 2022, v. 19, n. 1, p. 1, doi. 10.1186/s12981-022-00430-x
- By:
- Publication type:
- Article
Enhancement of Antiviral CD8+ T-Cell Responses and Complete Remission of Metastatic Melanoma in an HIV-1-Infected Subject Treated with Pembrolizumab.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 12, p. 2089, doi. 10.3390/jcm8122089
- By:
- Publication type:
- Article
Comparative Analysis of Primary and Monovalent Booster SARS-CoV-2 Vaccination Coverage in Adults with and without HIV in Catalonia, Spain.
- Published in:
- Vaccines, 2024, v. 12, n. 1, p. 44, doi. 10.3390/vaccines12010044
- By:
- Publication type:
- Article
Commentary: Long-Term Changes of Inflammatory Biomarkers in Individuals on Suppressive Three-Drug or Two-Drug Antiretroviral Regimens.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.904689
- By:
- Publication type:
- Article
HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects.
- Published in:
- Nature Medicine, 2010, v. 16, n. 4, p. 460, doi. 10.1038/nm.2111
- By:
- Publication type:
- Article
Overdose of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in an HIV-1-infected subject with attempted suicide.
- Published in:
- Infection, 2019, v. 47, n. 1, p. 115, doi. 10.1007/s15010-018-1201-x
- By:
- Publication type:
- Article
Effectiveness of a Treatment Switch to Nevirapine plus Tenofovir and Emtricitabine (or Lamivudine) in Adults with HIV-1 Suppressed Viremia.
- Published in:
- PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0128131
- By:
- Publication type:
- Article
Different Plasma Markers of Inflammation Are Influenced by Immune Recovery and cART Composition or Intensification in Treated HIV Infected Individuals.
- Published in:
- PLoS ONE, 2014, v. 9, n. 12, p. 1, doi. 10.1371/journal.pone.0114142
- By:
- Publication type:
- Article
Effect of Maraviroc Intensification on HIV-1-Specific T Cell Immunity in Recently HIV-1-Infected Individuals.
- Published in:
- PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0087334
- By:
- Publication type:
- Article
Virological Efficacy in Cerebrospinal Fluid and Neurocognitive Status in Patients with Long-Term Monotherapy Based on Lopinavir/Ritonavir: An Exploratory Study.
- Published in:
- PLoS ONE, 2013, v. 8, n. 7, p. 1, doi. 10.1371/journal.pone.0070201
- By:
- Publication type:
- Article
Antiretroviral Simplification with Darunavir/Ritonavir Monotherapy in Routine Clinical Practice: Safety, Effectiveness, and Impact on Lipid Profile.
- Published in:
- PLoS ONE, 2012, v. 7, n. 5, p. 1, doi. 10.1371/journal.pone.0037442
- By:
- Publication type:
- Article
Determinants of Depressive Symptoms in People Living with HIV: Findings from a Population-Based Study with a Gender Perspective.
- Published in:
- International Journal of Environmental Research & Public Health, 2023, v. 20, n. 4, p. 3687, doi. 10.3390/ijerph20043687
- By:
- Publication type:
- Article
Screening for SARS-CoV-2 Antigen Before a Live Indoor Music Concert: An Observational Study.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Fanconi Syndrome and Tenofovir Alafenamide.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Virologic and immunologic outcomes of treatment with integrase inhibitors in a real-world setting: The RESPOND cohort consortium.
- Published in:
- PLoS ONE, 2020, v. 15, n. 12, p. 1, doi. 10.1371/journal.pone.0243625
- By:
- Publication type:
- Article
Mpox: Clinical Outcomes and Impact of Vaccination in People with and without HIV: A Population-Wide Study.
- Published in:
- Microorganisms, 2023, v. 11, n. 11, p. 2701, doi. 10.3390/microorganisms11112701
- By:
- Publication type:
- Article
Impact of the Introduction of a Two-Step Laboratory Diagnostic Algorithm in the Incidence and Earlier Diagnosis of Clostridioides difficile Infection.
- Published in:
- Microorganisms, 2022, v. 10, n. 5, p. 1075, doi. 10.3390/microorganisms10051075
- By:
- Publication type:
- Article
SARS-CoV-2 Evolution and Spike-Specific CD4+ T-Cell Response in Persistent COVID-19 with Severe HIV Immune Suppression.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Male genitourinary schistosomiasis-related symptoms among long-term Western African migrants in Spain: a prospective population-based screening study.
- Published in:
- Infectious Diseases of Poverty, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40249-024-01190-8
- By:
- Publication type:
- Article
IP-10 and MIG are sensitive markers of early virological response to HIV-1 integrase inhibitors.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1257725
- By:
- Publication type:
- Article
Strategies to reengage patients lost to follow up in HIV care in high income countries, a scoping review.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Characteristics, Comorbidities, and Outcomes in a Multicenter Registry of Patients With Human Immunodeficiency Virus and Coronavirus Disease 2019.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 7, p. e1964, doi. 10.1093/cid/ciaa1339
- By:
- Publication type:
- Article
Routine Screening of Anal Cytology in Persons With Human Immunodeficiency Virus and the Impact on Invasive Anal Cancer: A Prospective Cohort Study.
- Published in:
- Clinical Infectious Diseases, 2020, v. 71, n. 2, p. 390, doi. 10.1093/cid/ciz831
- By:
- Publication type:
- Article
The Lipid-Lowering Effect of Tenofovir/Emtricitabine: A Randomized, Crossover, Double-Blind, Placebo-Controlled Trial.
- Published in:
- Clinical Infectious Diseases, 2015, v. 61, n. 3, p. 403, doi. 10.1093/cid/civ296
- By:
- Publication type:
- Article
Deep Molecular Characterization of HIV-1 Dynamics under Suppressive HAART.
- Published in:
- PLoS Pathogens, 2011, v. 7, n. 10, p. 1, doi. 10.1371/journal.ppat.1002314
- By:
- Publication type:
- Article
Feasibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen self-testing in school and summer camp attendees.
- Published in:
- Frontiers in Pediatrics, 2024, p. 01, doi. 10.3389/fped.2022.975454
- By:
- Publication type:
- Article
Who is lost to follow‐up in HIV care? Assessment of care retention over time and the impact of COVID‐19. Longitudinal analysis of the PISCIS cohort.
- Published in:
- HIV Medicine, 2023, v. 24, n. 9, p. 965, doi. 10.1111/hiv.13486
- By:
- Publication type:
- Article
Predictors of low‐level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort.
- Published in:
- HIV Medicine, 2022, v. 23, n. 8, p. 825, doi. 10.1111/hiv.13265
- By:
- Publication type:
- Article
The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA study.
- Published in:
- HIV Medicine, 2022, v. 23, n. 6, p. 585, doi. 10.1111/hiv.13210
- By:
- Publication type:
- Article
Changes in Inflammatory Biomarkers and Baseline Variables After Switching to Dolutegravir/Lamivudine(DTG/3TC) in 2 Randomized Clinical Trials of Virologically Suppressed Adults: 48-Week Pooled Analysis.
- Published in:
- Infection & Chemotherapy, 2022, v. 54, p. 272
- By:
- Publication type:
- Article
Hidden costs of antiretroviral treatment: the public health efficiency of drug packaging.
- Published in:
- Drug Design, Development & Therapy, 2015, v. 9, p. 4287, doi. 10.2147/DDDT.S87075
- By:
- Publication type:
- Article
Correction: An Indirect Comparison of Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate and Abacavir/Lamivudine + Dolutegravir in Initial Therapy.
- Published in:
- 2016
- By:
- Publication type:
- Correction Notice
An Indirect Comparison of Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate and Abacavir/Lamivudine + Dolutegravir in Initial Therapy.
- Published in:
- PLoS ONE, 2016, v. 11, n. 5, p. 1, doi. 10.1371/journal.pone.0155406
- By:
- Publication type:
- Article
EPICE-HIV: An Epidemiologic Cost-Effectiveness Model for HIV Treatment.
- Published in:
- PLoS ONE, 2016, v. 11, n. 2, p. 1, doi. 10.1371/journal.pone.0149007
- By:
- Publication type:
- Article